Usage and dosage of ulinastatin：
1, acute pancreatitis, chronic recurrent pancreatitis, at the initial stage of each l00, 000 units dissolved in 500ML 5% glucose injection or intravenous infusion, each intravenous drip for 1 to 2 hours, 1 to 3 times a day, and then decreased as the symptoms subsided;
2. For acute circulative failure, 100,000 units were dissolved in 500ml5% glucose injection or sodium chloride injection intravenous infusion, left for 1 to 2 hours each time, 1-3 times a day, or 100,000 units were dissolved in 5 to 10ml sodium chloride injection, slowly intravenous injection for 1 to 3 times a day. And can be based on age, symptoms appropriate increase or decrease.
Ulinastatin Adverse reactions：
1. Blood system: Leukopenia or eosinophilic granulocytosis are occasionally observed;
2. Digestive system: Occasional nausea, vomiting and diarrhea, and occasional elevation of AST and ALT;
3. Injection site: blood vessel pain, redness, pruritus, rash, etc.
4, occasionally allergic, allergic symptoms should be immediately stopped, and appropriate treatment.
Ulinastatin for Pregnant and lactating women：
The safety of drug administration during pregnancy has not been demonstrated, and animal studies (mice) have shown drug distribution in breast milk. Therefore, pregnant women and women who may be pregnant should be judged according to the disease, the need for caution. Breastfeeding women should avoid breastfeeding if necessary.